$2.93 Million is the total value of TANG KEVIN's 2 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LJPC | LA JOLLA PHARMACEUTICAL CO | $2,220,000 | +43.9% | 240,000 | 0.0% | 75.87% | +22.7% | |
| HRTX | Sell | HERON THERAPEUTICS INC | $706,000 | -25.8% | 37,999 | -2.4% | 24.13% | -36.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERON THERAPEUTICS INC | 19 | Q3 2023 | 100.0% |
| LA JOLLA PHARMACEUTICAL CO | 14 | Q2 2022 | 99.7% |
View TANG KEVIN's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ACLARA BIOSCIENCES INC | July 24, 2002 | 486,900 | 1.4% |
| INTRABIOTICS PHARMACEUTICALS INC /DE | July 24, 2002 | 474,900 | 1.3% |
View TANG KEVIN's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-09-18 |
| 4 | 2024-09-18 |
| N-PX | 2024-08-30 |
| 13F-NT | 2024-08-14 |
| 13F-NT | 2024-05-15 |
| 13F-NT | 2024-02-14 |
| 4 | 2024-02-14 |
| 4 | 2024-02-02 |
| 4 | 2023-12-18 |
| 13F-HR | 2023-11-14 |
View TANG KEVIN's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.